When you think about how much money is at stake when it comes to making sure your loved ones live a life free of cancer, you might think about buying a drug to combat it.
And you would be right to think so, but a new study suggests that, to be considered for a new drug, you’ll need to be able to prove you’re cancer-free before you can get it.
The study, which was led by the American Cancer Society, also found that those with more than $5,000 in annual household income needed to be willing to give up some of their income for the drug.
Those with incomes below that level needed to take at least 10% of their annual income in order to be eligible for the trial.
The researchers from the University of Minnesota, who also included doctors, nurses and patients themselves, looked at more than 4,000 people in the United States with a history of cancer and asked them how they would feel if they were offered a drug with an FDA-approved safety profile.
If a person were offered the drug, they would likely want to take it.
But how much would they want to pay?
The study found that people who were offered drugs with FDA approval in the last year of life had a median monthly income of $1,700, a median annual household salary of $60,000 and a median age of 66.
They were also the least likely to have a chronic disease such as cancer, heart disease or diabetes.
The average price for a drug was $1.17 per pill, with some companies offering lower prices for some patients.
If a person had a diagnosis of cancer at age 50, they were at least 18% less likely to be offered a trial drug.
The drug was approved for use in humans on November 17, 2017, and the trial will begin in March 2018.